Genetic environment of quinolone resistance gene qnrB2 in a complex sul1-type integron in the newly described Salmonella enterica serovar Keurmassar.

PubWeight™: 1.34‹?› | Rank: Top 10%

🔗 View Article (PMC 1563520)

Published in Antimicrob Agents Chemother on September 01, 2006

Authors

Fabien Garnier1, Nabil Raked, Amy Gassama, François Denis, Marie-Cécile Ploy

Author Affiliations

1: Laboratoire de Bactériologie-Virologie-Hygiène, EA3175, CHU Dupuytren, 87042 Limoges Cedex, France.

Articles citing this

Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev (2009) 4.43

Prevalence of plasmid-mediated quinolone resistance determinants QnrA, QnrB, and QnrS among clinical isolates of Enterobacter cloacae in a Taiwanese hospital. Antimicrob Agents Chemother (2007) 1.97

High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals. Antimicrob Agents Chemother (2008) 1.83

Complex class 1 integrons with diverse variable regions, including aac(6')-Ib-cr, and a novel allele, qnrB10, associated with ISCR1 in clinical enterobacterial isolates from Argentina. Antimicrob Agents Chemother (2007) 1.67

Predictive analysis of transmissible quinolone resistance indicates Stenotrophomonas maltophilia as a potential source of a novel family of Qnr determinants. BMC Microbiol (2008) 1.59

Plasmid-Mediated Quinolone Resistance; Interactions between Human, Animal, and Environmental Ecologies. Front Microbiol (2012) 1.38

GES-11, a novel integron-associated GES variant in Acinetobacter baumannii. Antimicrob Agents Chemother (2009) 1.36

ISEcp1-mediated transposition of qnrB-like gene in Escherichia coli. Antimicrob Agents Chemother (2008) 1.24

Mobilization of qnrB2 and ISCR1 in plasmids. Antimicrob Agents Chemother (2008) 1.19

The SOS response promotes qnrB quinolone-resistance determinant expression. EMBO Rep (2009) 1.18

Quinolone resistance: much more than predicted. Front Microbiol (2011) 1.14

Plasmid-mediated quinolone resistance. Microbiol Spectr (2014) 1.13

Characterization of the plasmid-borne quinolone resistance gene qnrB19 in Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother (2009) 0.96

The co-selection of fluoroquinolone resistance genes in the gut flora of Vietnamese children. PLoS One (2012) 0.94

Spread of ISCR1 elements containing blaDHA-₁ and multiple antimicrobial resistance genes leading to increase of flomoxef resistance in extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae. Antimicrob Agents Chemother (2011) 0.94

Differential distribution of plasmid-mediated quinolone resistance genes in clinical enterobacteria with unusual phenotypes of quinolone susceptibility from Argentina. Antimicrob Agents Chemother (2013) 0.93

Use of inverse PCR for analysis of class 1 integrons carrying an unusual 3' conserved segment structure. Antimicrob Agents Chemother (2010) 0.83

Tracking Change: A Look at the Ecological Footprint of Antibiotics and Antimicrobial Resistance. Antibiotics (Basel) (2013) 0.75

Genetic characterization of three qnrS1-harbouring multidrug-resistance plasmids and qnrS1-containing transposons circulating in Ho Chi Minh City, Vietnam. J Med Microbiol (2015) 0.75

First Description of the Extended Spectrum-Beta-Lactamase Gene blaCTX-M-109 in Salmonella Grumpensis Strains Isolated from Neonatal Nosocomial Infections in Dakar, Senegal. PLoS One (2016) 0.75

Articles cited by this

Quinolone resistance from a transferable plasmid. Lancet (1998) 11.28

Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b. Antimicrob Agents Chemother (2005) 4.74

Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae. J Antimicrob Chemother (2005) 4.65

Mechanisms of resistance to quinolones. Clin Infect Dis (2005) 4.02

Origin of plasmid-mediated quinolone resistance determinant QnrA. Antimicrob Agents Chemother (2005) 3.18

In34, a complex In5 family class 1 integron containing orf513 and dfrA10. Antimicrob Agents Chemother (2003) 2.94

The partial 3'-conserved segment duplications in the integrons In6 from pSa and In7 from pDGO100 have a common origin. Plasmid (1993) 2.87

A novel integron in Salmonella enterica serovar Enteritidis, carrying the bla(DHA-1) gene and its regulator gene ampR, originated from Morganella morganii. Antimicrob Agents Chemother (2000) 2.85

DNA sequence analysis of the genetic environment of various blaCTX-M genes. J Antimicrob Chemother (2005) 2.59

Novel complex sul1-type integron in Escherichia coli carrying bla(CTX-M-9). Antimicrob Agents Chemother (2002) 2.49

blaCTX-M-2 is located in an unusual class 1 integron (In35) which includes Orf513. Antimicrob Agents Chemother (2002) 2.47

Novel class 1 integron (InS21) carrying blaCTX-M-2 in Salmonella enterica serovar infantis. Antimicrob Agents Chemother (2002) 2.43

Molecular characterization of integrons in Acinetobacter baumannii: description of a hybrid class 2 integron. Antimicrob Agents Chemother (2000) 2.25

Vibrionaceae as a possible source of Qnr-like quinolone resistance determinants. J Antimicrob Chemother (2005) 2.17

DNA sequence of direct repeats of the sulI gene of plasmid pSa. Plasmid (1994) 2.00

A new trimethoprim resistance gene, dhfrX, in the In7 integron of plasmid pDGO100. Antimicrob Agents Chemother (1991) 1.98

Integron-containing IncU R plasmids pRAS1 and pAr-32 from the fish pathogen Aeromonas salmonicida. Antimicrob Agents Chemother (2003) 1.51

Emergence of DHA-1-producing Klebsiella spp. in the Parisian region: genetic organization of the ampC and ampR genes originating from Morganella morganii. Antimicrob Agents Chemother (2006) 1.51

Characterization of a novel plasmid-mediated cephalosporinase (CMY-9) and its genetic environment in an Escherichia coli clinical isolate. Antimicrob Agents Chemother (2002) 1.43

Composite integron array generated by insertion of an ORF341-type integron within a Tn21-like element. Microb Drug Resist (2002) 1.11

Integrons in Salmonella Keurmassar, Senegal. Emerg Infect Dis (2004) 0.87

Articles by these authors

The SOS response controls integron recombination. Science (2009) 2.27

Inverse correlation between promoter strength and excision activity in class 1 integrons. PLoS Genet (2010) 1.68

Ribavirin exposure after the first dose is predictive of sustained virological response in chronic hepatitis C. Hepatology (2008) 1.62

Integron involvement in environmental spread of antibiotic resistance. Front Microbiol (2012) 1.52

Human papillomavirus genotype distribution in anal cancer in France: the EDiTH V study. Int J Cancer (2010) 1.38

A 1 year surveillance study of glycopeptide-intermediate Staphylococcus aureus strains in a French hospital. J Antimicrob Chemother (2005) 1.33

Pneumonia and new methicillin-resistant Staphylococcus aureus clone. Emerg Infect Dis (2006) 1.28

Safety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa: a randomized,double-blind, placebo-controlled trial. Crit Care Med (2012) 1.28

The SOS response promotes qnrB quinolone-resistance determinant expression. EMBO Rep (2009) 1.18

Integron-associated antibiotic resistance in Salmonella enterica serovar typhi from Asia. Antimicrob Agents Chemother (2003) 1.16

Intracellular adaptation of Brucella abortus. J Proteome Res (2009) 1.13

Type II topoisomerase mutations in clinical isolates of Enterobacter cloacae and other enterobacterial species harbouring the qnrA gene. Int J Antimicrob Agents (2007) 1.11

Human papillomavirus genotype distribution in oropharynx and oral cavity cancer in France--The EDiTH VI study. J Clin Virol (2011) 1.07

Herpes simplex virus DNA in corneal transplants: prospective study of 38 recipients. J Med Virol (2003) 1.05

Influence of reduced susceptibility to glycopeptides on activities of vancomycin and teicoplanin against Staphylococcus aureus in experimental endocarditis. Antimicrob Agents Chemother (2003) 1.04

Hepatitis B mother--to--child transmission. Expert Rev Anti Infect Ther (2004) 1.01

Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. Antivir Ther (2008) 0.97

High-level gene cassette transcription prevents integrase expression in class 1 integrons. J Bacteriol (2011) 0.94

Emergence of Streptococcus pneumoniae of serotype 19A in France: molecular capsular serotyping, antimicrobial susceptibilities, and epidemiology. Diagn Microbiol Infect Dis (2009) 0.93

Multiplex detection of herpesviruses in tear fluid using the "stair primers" PCR method: prospective study of 93 patients. J Med Virol (2002) 0.90

Human papillomavirus genotype distribution in tonsil cancers. Head Neck Oncol (2011) 0.90

New functional domains of human cytomegalovirus pUL89 predicted by sequence analysis and three-dimensional modelling of the catalytic site DEXDc. Antivir Ther (2007) 0.89

Severe human bone infection due to methicillin-resistant Staphylococcus aureus carrying the novel mecC variant. J Antimicrob Chemother (2013) 0.88

Integrons in Salmonella Keurmassar, Senegal. Emerg Infect Dis (2004) 0.87

CD1d-unrestricted human NKT cells release chemokines upon Fas engagement. Blood (2004) 0.87

Interest of postmortem-collected specimens in the diagnosis of fulminant meningococcal sepsis. Diagn Microbiol Infect Dis (2005) 0.86

Serological pattern 'anti-hepatitis B core alone' in HIV or hepatitis C virus-infected patients is not fully explained by hepatitis B surface antigen mutants. AIDS (2004) 0.86

Alcaligenes xylosoxidans endophthalmitis following phacoemulsification and intraocular lens implantation. Ophthalmic Surg Lasers Imaging (2008) 0.86

Specific antibody production in herpes keratitis: intraocular inflammation and corneal neovascularisation as predicting factors. Graefes Arch Clin Exp Ophthalmol (2005) 0.84

Diversity of class 1 integron gene cassette Pc promoter variants in clinical Escherichia coli strains and description of a new P2 promoter variant. Int J Antimicrob Agents (2011) 0.84

Moxifloxacin efficacy and vitreous penetration in a rabbit model of Staphylococcus aureus endophthalmitis and effect on gene expression of leucotoxins and virulence regulator factors. Antimicrob Agents Chemother (2003) 0.83

High prevalence of trimethoprim-resistance cassettes in class 1 and 2 integrons in Senegalese Shigella spp isolates. J Infect Dev Ctries (2010) 0.83

Semimechanistic pharmacokinetic-pharmacodynamic model with adaptation development for time-kill experiments of ciprofloxacin against Pseudomonas aeruginosa. Antimicrob Agents Chemother (2010) 0.83

Undiagnosed airflow limitation in patients at cardiovascular risk. Arch Cardiovasc Dis (2011) 0.83

Dynamic assessment of the floc morphology, bacterial diversity, and integron content of an activated sludge reactor processing hospital effluent. Environ Sci Technol (2013) 0.81

Interest of LQAS method in a survey of HTLV-I infection in Benin (West Africa). J Clin Epidemiol (2002) 0.81

Two-step bacterial broad-range polymerase chain reaction analysis of heart valve tissue improves bacteriological diagnosis of infective endocarditis. Diagn Microbiol Infect Dis (2013) 0.81

Multiplex real-time PCR assay for simultaneous quantitation of human cytomegalovirus and herpesvirus-6 in polymorphonuclear and mononuclear cells of transplant recipients. J Virol Methods (2005) 0.81

Complete posttranslational modification mapping of pathogenic Neisseria meningitidis pilins requires top-down mass spectrometry. Proteomics (2014) 0.81

Conserved domains and structure prediction of human cytomegalovirus UL27 protein. Antivir Ther (2009) 0.80

[The SOS response controls antibiotic resistance by regulating the integrase of integrons]. Med Sci (Paris) (2010) 0.80

Seroreversion from hepatitis C after needlestick injury. Clin Infect Dis (2002) 0.80

Maternofetal infections due to Eikenella corrodens. J Med Microbiol (2009) 0.80

[Objectives: Vaccination is an effective way to reduce morbidity and mortality related to infectious diseases. In France, primary care physicians are the main administrators of vaccines. Our objective was to conduct an exploratory qualitative study with primary care physicians to identify determinants of their commitment to vaccination. Methods: A qualitative research study was conducted with 36&#160;primary care physicians from different geographical regions in France. Six focus group discussions, following a semi-structured interview guide, were held. Qualitative analysis based on coding of the transcribed discussions was performed to identify the factors influencing primary care physicians&#8217; attitudes toward vaccination. These factors were then organized into themes. Saturation was also evaluated. Results: Diphtheria, tetanus, poliomyelitis, measles, mumps, rubella, hepatitis B, tuberculosis, pneumococcal infections, meningococcus, human papillomavirus, rotavirus, pertussis, varicella and flu vaccinations were all discussed in each focus group. Saturation was reached from the fourth focus group. Forty identified determinants were divided into six themes: vaccine characteristics, disease characteristics, primary care physicians&#8217; past experience, practical aspects, expected benefits and primary care physician-patient relationship.<np pagenum="020"/> Conclusions]. Sante Publique (2016) 0.80

Early selection of a new UL97 mutant with a severe defect of ganciclovir phosphorylation after valaciclovir prophylaxis and short-term ganciclovir therapy in a renal transplant recipient. Antimicrob Agents Chemother (2005) 0.79

Eight flavonoids and their potential as inhibitors of human cytomegalovirus replication. Antiviral Res (2012) 0.79

A reverse transcription-nested PCR assay for HHV-6 mRNA early transcript detection after transplantation. J Virol Methods (2006) 0.79

Antimicrobial drug resistance in Corynebacterium diphtheriae mitis. Emerg Infect Dis (2011) 0.78

Transmission of viruses through corneal transplantation. Clin Lab (2005) 0.78

[New routes of administration: epidermal, transcutaneous mucosal ways of vaccination]. Med Sci (Paris) (2007) 0.78

Diversity of gene cassette promoters in class 1 integrons from wastewater environments. Appl Environ Microbiol (2012) 0.78

Molecular study of vancomycin-resistant enterococci isolated from humans and from food in a cattle-rearing area of France. J Antimicrob Chemother (2004) 0.78

Construction and functional screening of a metagenomic library using a T7 RNA polymerase-based expression cosmid vector. J Ind Microbiol Biotechnol (2010) 0.78

Internal and external contamination of donor corneas before in situ excision: bacterial risk factors in 93 donors. Graefes Arch Clin Exp Ophthalmol (2002) 0.78

Pacemaker-associated Bacillus cereus endocarditis. Diagn Microbiol Infect Dis (2012) 0.77

High incidence of vancomycin resistance in Enterococcus faecalis strains in a French hospital. Int J Antimicrob Agents (2004) 0.77

Insertion sequence 1515 in the ply gene of a type 1 clinical isolate of Streptococcus pneumoniae abolishes pneumolysin expression. J Clin Microbiol (2007) 0.77

Cloning and functional characterization of the murine caspase-3 gene promoter. DNA Cell Biol (2006) 0.77

Adaptation of the highly productive T7 expression system to Streptomyces lividans. Appl Environ Microbiol (2009) 0.77

Nur77 forms novel nuclear structures upon DNA damage that cause transcriptional arrest. Exp Cell Res (2006) 0.77

Multilocus variable-number tandem-repeat analysis-confirmed emergence of a macrolide resistance-associated mutation in Mycoplasma pneumoniae during macrolide therapy for interstitial pneumonia in an immunocompromised child. J Clin Microbiol (2012) 0.76

Ribavirin in chronic hepatitis C: past and future. Expert Rev Anti Infect Ther (2009) 0.76

Antimicrobial resistance data on 16,756 Streptococcus pneumoniae isolates in 1999: A Pan-Regional Multicenter Surveillance Study in France. Microb Drug Resist (2005) 0.76

Interferon alpha and ribavirin for membranoproliferative glomerulonephritis and hepatitis C infection. Am J Med (2002) 0.75

Early bacterial genome detection in body fluids from patients with severe sepsis: a pilot study. J Crit Care (2012) 0.75

Influence of calcium ions in the flow cytometric analysis of human CD8-positive cells. Cytometry A (2004) 0.75

Description of an unusual class 2 integron in Shigella sonnei isolates in Senegal (sub-Saharan Africa). J Antimicrob Chemother (2008) 0.75

The survival of herpes simplex virus in preserved murine corneas. Ophthalmic Res (2008) 0.75

Restriction analysis of recombinant plasmids from colonies in less than 30 min. Anal Biochem (2005) 0.75

Emergence of 2 Neisseria meningitidis serogroup C clones in a French county. Diagn Microbiol Infect Dis (2011) 0.75

[Vaccination coverage against HPV is still too low in France!]. Rev Prat (2014) 0.75

[Resistance acquisition via the bacterial SOS response: the inducive role of antibiotics]. Med Sci (Paris) (2012) 0.75

[Anti-papillomavirus vaccines and prevention of cervical cancer: progress and prospects]. Presse Med (2005) 0.75

Serotype distribution and antibiotic resistance of Streptococcus pneumoniae strains isolated from adults in France: evolution between 2001 and 2003. Microb Drug Resist (2009) 0.75

[Frequency of psychotic-like symptoms among adults consulting general practitioners]. Presse Med (2005) 0.75